188 related articles for article (PubMed ID: 29589276)
21. Sigma 1 receptor stimulation protects against oxidative damage through suppression of the ER stress responses in the human lens.
Wang L; Eldred JA; Sidaway P; Sanderson J; Smith AJ; Bowater RP; Reddan JR; Wormstone IM
Mech Ageing Dev; 2012; 133(11-12):665-74. PubMed ID: 23041531
[TBL] [Abstract][Full Text] [Related]
22. A novel phenoxy thiophene sulphonamide molecule protects against glutamate evoked oxidative injury in a neuronal cell model.
Gliyazova NS; Huh EY; Ibeanu GC
BMC Neurosci; 2013 Sep; 14():93. PubMed ID: 24004478
[TBL] [Abstract][Full Text] [Related]
23. Differentiation of sigma ligand-activated receptor subtypes that modulate NMDA-evoked [3H]-noradrenaline release in rat hippocampal slices.
Monnet FP; de Costa BR; Bowen WD
Br J Pharmacol; 1996 Sep; 119(1):65-72. PubMed ID: 8872358
[TBL] [Abstract][Full Text] [Related]
24. Multiple pathways of sigma(1) receptor ligand uptakes into primary cultured neuronal cells.
Yamamoto H; Karasawa J; Sagi N; Takahashi S; Horikomi K; Okuyama S; Nukada T; Sora I; Yamamoto T
Eur J Pharmacol; 2001 Aug; 425(1):1-9. PubMed ID: 11672569
[TBL] [Abstract][Full Text] [Related]
25. Neuroprotective Effects of Kinetin Against Glutamate-Induced Oxidative Cytotoxicity in HT22 Cells: Involvement of Nrf2 and Heme Oxygenase-1.
Wei Y; Liu D; Zheng Y; Hao C; Li H; Ouyang W
Neurotox Res; 2018 May; 33(4):725-737. PubMed ID: 28900849
[TBL] [Abstract][Full Text] [Related]
26. Using sigma-ligands as part of a multi-receptor approach to target diseases of the brain.
Brimson JM; Brimson S; Chomchoei C; Tencomnao T
Expert Opin Ther Targets; 2020 Oct; 24(10):1009-1028. PubMed ID: 32746649
[TBL] [Abstract][Full Text] [Related]
27. Sigma-1 receptor stimulation protects retinal ganglion cells from ischemia-like insult through the activation of extracellular-signal-regulated kinases 1/2.
Mueller BH; Park Y; Ma HY; Dibas A; Ellis DZ; Clark AF; Yorio T
Exp Eye Res; 2014 Nov; 128():156-69. PubMed ID: 25305575
[TBL] [Abstract][Full Text] [Related]
28. Sigma-1 receptor agonists provide neuroprotection against gp120 via a change in bcl-2 expression in mouse neuronal cultures.
Zhang Y; Shi Y; Qiao L; Sun Y; Ding W; Zhang H; Li N; Chen D
Brain Res; 2012 Jan; 1431():13-22. PubMed ID: 22133307
[TBL] [Abstract][Full Text] [Related]
29. Role of calcium in sigma-mediated neuroprotection in rat primary cortical neurons.
Klette KL; DeCoster MA; Moreton JE; Tortella FC
Brain Res; 1995 Dec; 704(1):31-41. PubMed ID: 8750959
[TBL] [Abstract][Full Text] [Related]
30. 4-iodophenyl isothiocyanate: a neuroprotective compound.
Wellejus A; Elbrønd-Bek H; Kelly NM; Weidner MS; Jørgensen SH
Restor Neurol Neurosci; 2012; 30(1):21-38. PubMed ID: 22082767
[TBL] [Abstract][Full Text] [Related]
31. Compromising σ-1 receptors at the endoplasmic reticulum render cytotoxicity to physiologically relevant concentrations of dopamine in a nuclear factor-κB/Bcl-2-dependent mechanism: potential relevance to Parkinson's disease.
Mori T; Hayashi T; Su TP
J Pharmacol Exp Ther; 2012 Jun; 341(3):663-71. PubMed ID: 22399814
[TBL] [Abstract][Full Text] [Related]
32. Protection by imidazol(ine) drugs and agmatine of glutamate-induced neurotoxicity in cultured cerebellar granule cells through blockade of NMDA receptor.
Olmos G; DeGregorio-Rocasolano N; Paz Regalado M; Gasull T; Assumpció Boronat M; Trullas R; Villarroel A; Lerma J; García-Sevilla JA
Br J Pharmacol; 1999 Jul; 127(6):1317-26. PubMed ID: 10455281
[TBL] [Abstract][Full Text] [Related]
33. The dopamine stabilizers ACR16 and (-)-OSU6162 display nanomolar affinities at the σ-1 receptor.
Sahlholm K; Århem P; Fuxe K; Marcellino D
Mol Psychiatry; 2013 Jan; 18(1):12-4. PubMed ID: 22349783
[No Abstract] [Full Text] [Related]
34. Sigma-1 Receptors and Neurodegenerative Diseases: Towards a Hypothesis of Sigma-1 Receptors as Amplifiers of Neurodegeneration and Neuroprotection.
Nguyen L; Lucke-Wold BP; Mookerjee S; Kaushal N; Matsumoto RR
Adv Exp Med Biol; 2017; 964():133-152. PubMed ID: 28315269
[TBL] [Abstract][Full Text] [Related]
35. Some of the effects of the selective sigma ligand (+)pentazocine are mediated via a naloxone-sensitive receptor.
Couture S; Debonnel G
Synapse; 2001 Mar; 39(4):323-31. PubMed ID: 11169783
[TBL] [Abstract][Full Text] [Related]
36. Biochemical and morphological analysis of non-NMDA receptor mediated excitotoxicity in chick embryo retina.
Chen Q; Olney JW; Price MT; Romano C
Vis Neurosci; 1999; 16(1):131-9. PubMed ID: 10022484
[TBL] [Abstract][Full Text] [Related]
37. Neuroprotective sigma ligands attenuate NMDA and trans-ACPD-induced calcium signaling in rat primary neurons.
Klette KL; Lin Y; Clapp LE; DeCoster MA; Moreton JE; Tortella FC
Brain Res; 1997 May; 756(1-2):231-40. PubMed ID: 9187337
[TBL] [Abstract][Full Text] [Related]
38. Small molecule modulator of sigma 2 receptor is neuroprotective and reduces cognitive deficits and neuroinflammation in experimental models of Alzheimer's disease.
Yi B; Sahn JJ; Ardestani PM; Evans AK; Scott LL; Chan JZ; Iyer S; Crisp A; Zuniga G; Pierce JT; Martin SF; Shamloo M
J Neurochem; 2017 Feb; 140(4):561-575. PubMed ID: 27926996
[TBL] [Abstract][Full Text] [Related]
39. Protective effect of dopamine D2 agonists in cortical neurons via the phosphatidylinositol 3 kinase cascade.
Kihara T; Shimohama S; Sawada H; Honda K; Nakamizo T; Kanki R; Yamashita H; Akaike A
J Neurosci Res; 2002 Nov; 70(3):274-82. PubMed ID: 12391586
[TBL] [Abstract][Full Text] [Related]
40. Rimcazole analogs attenuate the convulsive effects of cocaine: correlation with binding to sigma receptors rather than dopamine transporters.
Matsumoto RR; Hewett KL; Pouw B; Bowen WD; Husbands SM; Cao JJ; Newman AH
Neuropharmacology; 2001 Dec; 41(7):878-86. PubMed ID: 11684152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
